Promaxo, Inc.

OAKLAND, CA · Founded 2016 · Medtech · Private

Point-of-care MRI platform with live guidance, AI targeting, and robotic precision for prostate intervention

Claim this profile

Follows are private to you and power your alerts

Updated · promaxo.com

Sector
Medtech
Headquarters
OAKLAND, CA
Founded
2016
Latest Form D
$31.6M, Apr 2024
Total capital
$50.5M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$50.5M
4 Form D · last Apr 2024
31 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
15
25 pending · first 2020
Rank in peer group#148 of 1112

Capital timeline

20172018201920202021202220232024FEDERAL ↑EQUITY ↓Cumulative $50.5M1st Form D$3.8M2nd Form D$11M3rd Form D$4.2M4th Form D$31.6M
2017201920212023FEDERAL ↑EQUITY ↓Cumulative $50.5M2nd Form D$11M4th Form D$31.6M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$31.6M
  • Private capital raisedForm D · SEC · 3rd filing$4.2M
  • Private capital raisedForm D · SEC · 2nd filing$11M
  • Private capital raisedForm D · SEC · 1st filing$3.8M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#148 · top 13%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Amit VohraExecutive Officer, DirectorNamed in SEC Form D filings
  • Dan McCormickDirectorNamed in SEC Form D filings
  • Derek HenneckeDirectorNamed in SEC Form D filings
  • Dinesh KumarExecutive OfficerNamed in SEC Form D filings
  • Dushyant ChipalkattyDirectorNamed in SEC Form D filings
  • Jonathan ChenDirectorNamed in SEC Form D filings
Show all 7 people
  • Michael BartholomewExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 15 granted of 40
  • GrantedMri-guided Robotic Systems And Methods For BiopsyUSPTOUS 12,702,320
  • PendingSystems And Methods For Volumetric Acquisition In A Single-sided Mri ScannerUSPTOApplication 19317969
  • PendingCROSS-TERM SPATIOTEMPORAL ENCODING (xSPEN) TECHNIQUES FOR SINGLE-SIDED MRIUSPTOApplication 19261467
Show all 40 patent records
  • PROGENITEC, INC.Similar federal contract value in Medtech · null in contracts
  • Litmus Health, Inc.Similar federal contract value in Medtech · null in contracts
  • DECISIV INTERVENTIONS, LLCSimilar federal contract value in Medtech · null in contracts
  • SYNERGEYES INCSimilar federal contract value in Medtech · null in contracts
  • Metavention, Inc.Similar federal contract value in Medtech · null in contracts
  • NUMENTUS TECHNOLOGIES INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .